Kiora Pharmaceuticals Inc (KPRX) — Capital Reinvestment Ratio
Latest as of September 2024:
0.00x
Kiora Pharmaceuticals Inc (KPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($920.06K) in capital expenditures ($3.00). See free cash flow generation of Kiora Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$920.06K
USD
Capital Expenditures
$3.00
USD
Data as of
Sep 2024
Most recent filing
Kiora Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks Kiora Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Kiora Pharmaceuticals Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for Kiora Pharmaceuticals Inc from 2024 to 2024. For live market cap and broader valuation context, see Kiora Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $8.56 Million | $6.26K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow